Access to medicine and the dangers of patent linkage : lessons from Bayer Corp v. Union of India
Tsui, Mabel (2011) Access to medicine and the dangers of patent linkage : lessons from Bayer Corp v. Union of India. Journal of Law and Medicine, 18(3), pp. 577-588.
This is the latest version of this eprint.
In February 2010, the Delhi High Court delivered its decision in Bayer Corp v Union of India in which Bayer had appealed against an August 2009 decision of the same court. Both decisions prevented Bayer from introducing the concept of patent linkage into India’s drug regulatory regime. Bayer appealed to the Indian Supreme Court, the highest court in India, which agreed on 2 March 2010 to hear the appeal. Given that India is regarded as a global pharmaceutical manufacturer of generic medications, how its judiciary and government perceive their international obligations has a significant impact on the global access to medicines regime. In rejecting the application of patent linkage, the case provides an opportunity for India to further acknowledge its international human rights obligations.
Impact and interest:
Citation countsare sourced monthly fromand citation databases.
These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.
Citations counts from theindexing service can be viewed at the linked Google Scholar™ search.
Full-text downloadsdisplays the total number of times this work’s files (e.g., a PDF) have been downloaded from QUT ePrints as well as the number of downloads in the previous 365 days. The count includes downloads for all files if a work has more than one.
|Item Type:||Journal Article|
|Keywords:||TRIPS, access to medicine, India|
|Subjects:||Australian and New Zealand Standard Research Classification > LAW AND LEGAL STUDIES (180000) > LAW (180100) > Human Rights Law (180114)|
Australian and New Zealand Standard Research Classification > LAW AND LEGAL STUDIES (180000) > LAW (180100) > Intellectual Property Law (180115)
|Divisions:||Current > QUT Faculties and Divisions > Faculty of Law|
Current > Schools > School of Law
|Deposited On:||30 Mar 2011 10:28|
|Last Modified:||13 Apr 2011 16:28|
Available Versions of this Item
- Access to medicine and the dangers of patent linkage : lessons from Bayer Corp v Union of India. (deposited 14 Feb 2011 10:08)
- Access to medicine and the dangers of patent linkage : lessons from Bayer Corp v. Union of India. (deposited 30 Mar 2011 10:28)[Currently Displayed]
Repository Staff Only: item control page